# Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects

> **NCT02172313** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 78 (actual)

## Conditions studied

- Diabetes
- Healthy

## Interventions

- **DRUG:** semaglutide

## Key facts

- **NCT ID:** NCT02172313
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2014-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02172313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02172313, "Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02172313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*